GleamWall
中文EN

NRC NRC HEALTH

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 70487 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.4%
TTM net income YoY-60.6%
TTM EPS YoY6,909.9%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR-39.3%

Margins

Gross margin—
Operating margin11.1%
Net margin4.5%
FCF margin12.8%
EBITDA margin17.0%

Returns

ROE248.1%
ROA4.7%
ROIC (approx.)10.9%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets106.6%
Debt / equity—
Current ratio0.64x
Interest coverage2.91x

Cash quality & payout

Operating cash flow / net income3.69x
Accruals ratio-12.6%
Payout ratio209.2%
Capex / revenue3.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$38.40M$35.39M$34.80M$35.19M$34.61M$34.04M$33.55M$36.91M
SG&A expense$12.04M$22.95M$13.42M$14.45M$12.27M$17.73M$10.36M$11.45M
Operating income$8.91M-$3.24M$5.57M$4.67M$7.74M$1.59M$8.60M$9.59M
Interest expense$1.53M$1.32M$1.25M$1.37M$1.46M$1.03M$899,000$729,000
Pretax income$7.40M-$4.54M$4.38M$3.27M$6.27M$581,000$7.72M$8.88M
Income tax$2.70M-$1.25M$1.16M$1.47M$2.15M$687,000$1.94M$2.31M
Net income$4.70M-$3.28M$3.22M$1.80M$4.12M-$106,000$5.79M$6.56M
EBITDA$10.98M-$1.12M$7.74M$6.81M$9.93M$3.33M$10.14M$11.10M
EPS (basic)0.22-0.150.14—0.18-0.010.25—
EPS (diluted)0.21-0.150.14—0.18-0.010.25—
Dividends declared per share0.160.160.160.160.120.120.120.12
Weighted avg. shares (diluted)21.89M22.01M21.91M—22.13M22.66M22.97M—
Balance sheet
Cash & equivalents$3.63M$3.33M$2.55M$4.14M$2.22M$5.27M$2.50M$4.23M
Receivables$15.34M$9.32M$10.83M$11.11M$12.75M$12.42M$11.33M$11.05M
Current assets$26.71M$22.81M$19.98M$20.21M$20.40M$25.32M$20.40M$19.60M
PP&E, net$38.34M$39.50M$40.30M$40.47M$41.41M$42.23M$40.39M$38.27M
Goodwill$66.15M$66.15M$66.15M$66.15M$66.15M$66.15M$66.15M$66.15M
Intangibles$2.04M$2.10M$2.17M$2.23M$2.32M$2.42M$2.52M$2.62M
Total assets$139.21M$136.15M$134.56M$134.88M$135.72M$141.39M$135.18M$132.54M
Current liabilities$41.84M$35.02M$38.47M$36.62M$38.57M$35.93M$37.77M$35.86M
Short-term debt$4.77M$4.02M—$4.01M————
Long-term debt$98.13M$86.01M$74.02M$75.02M$76.03M$77.03M$58.67M$57.90M
Total debt$102.90M$90.03M$74.02M$79.03M$76.03M$77.03M$58.67M$57.90M
Total liabilities$148.34M$129.60M$121.06M$120.89M$121.41M$120.06M$105.50M$101.25M
Shareholders' equity-$9.12M$6.55M$13.49M$13.99M$14.31M$21.33M$29.67M$31.28M
Net debt$99.27M$86.70M$71.47M$74.90M$73.81M$71.75M$56.17M$53.66M
Shares outstanding21.22M22.14M22.54M22.64M22.66M23.10M22.79M23.08M
Cash flow statement
Operating cash flow$8.02M$1.39M$7.18M$7.18M$13.76M-$1.14M$6.65M$6.38M
Capital expenditure$1.04M$1.32M$1.83M$1.12M$3.59M$3.01M$2.99M$4.44M
Free cash flow$6.98M$62,000$5.35M$6.06M$10.18M-$4.15M$3.66M$1.94M
Investing cash flow-$1.04M-$1.32M-$1.83M-$1.12M-$3.59M-$3.01M-$2.99M-$4.44M
Financing cash flow-$6.68M$718,000-$6.94M-$4.14M-$13.23M$6.92M-$5.39M-$1.16M
Depreciation & amortization$2.07M$2.12M$2.17M$2.15M$2.19M$1.74M$1.54M$1.52M
Stock-based compensation-$135,000$7.37M$1.61M$1.91M$925,000$307,000$171,000$188,000
Dividends paid$3.54M$3.61M$3.62M$2.70M$2.78M$2.73M$2.77M$2.82M
Share buybacks$15.98M$7.64M$1.94M$1,000$9.27M$5.99M$4.92M$7.40M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.